Clinical Trials
60 trialsUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
Masonic Cancer Center, University of Minnesota
STIM 2
University Hospital, Bordeaux
ENERGIA
University of Turin, Italy
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
Ohio State University Comprehensive Cancer Center
BMT
Massachusetts General Hospital
HAPLOTAB
Baylor College of Medicine
Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
American University of Beirut Medical Center
DiP-in-CML
Gruppo Italiano Malattie EMatologiche dell'Adulto
A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia
Thomas Jefferson University
PHARM-LMC
Centre Hospitalier Universitaire de Saint Etienne
MargheRITA
Advice Pharma Group srl
BIO-TIMER
University Hospital, Clermont-Ferrand
EPIK
University Hospital, Clermont-Ferrand
The EMPATHY Pilot Study
Northwestern University
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
University of Tennessee
DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer
Barbara Ann Karmanos Cancer Institute
A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
University of California, San Francisco
Mini-allo
Scripps Health
Unrelated Donor Stem Cell Transplantation
Scripps Health
Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications
University of Michigan Rogel Cancer Center
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Pfizer
CAR-LMC
Centre Hospitalier Universitaire de Besancon
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
M.D. Anderson Cancer Center
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
H. Lee Moffitt Cancer Center and Research Institute
Myeloid Mutations Register in R/R CML
Grupo Cooperativo de HemopatÃas Malignas
IM-TMI
University of Illinois at Chicago
Unrelated Umbilical Cord Blood (UBC)Transplantation
West Virginia University
Stem Cell Transplant for Hematological Malignancy
Masonic Cancer Center, University of Minnesota
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Dartmouth-Hitchcock Medical Center
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life
Radboud University Medical Center
TAR
Baylor College of Medicine
Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy
Nanfang Hospital, Southern Medical University
Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
Masonic Cancer Center, University of Minnesota
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
National Institutes of Health Clinical Center (CC)
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Ann & Robert H Lurie Children's Hospital of Chicago
To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission
Command Hospital, India
Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients
UCSI University
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
University of Illinois at Chicago
Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes
M.D. Anderson Cancer Center
Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy
Rex Cancer Center, Raleigh, NC
Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
Rex Cancer Center, Raleigh, NC
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
Masonic Cancer Center, University of Minnesota
TAKE-IT
Rabin Medical Center
An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
King Faisal Specialist Hospital & Research Center
Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients
M.D. Anderson Cancer Center
In-Vivo Activated T-Cell Depletion to Prevent GVHD
Indiana University
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Natural Killer Index From Hematopoietic Stem Cell Graft
Nantes University Hospital
Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib
Seoul St. Mary's Hospital